Asosiy kontentga oʻtish
Sharh maqola

Gut microbiota shapes cancer immunotherapy responses

Wanting LeiXinqiao HospitalKexun ZhouDivision of Abdominal Cancer, Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 610041, ChengDu, Sichuan, ChinaYe LeiCollege of Liberal Arts, Neijiang Normal University, 641100, Neijiang, Sichuan, ChinaQiu LiDepartment of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, ChinaHong ZhuDivision of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. [email protected]
2025en
ABI

Annotatsiya

The gut microbiota significantly influences cancer immunotherapy efficacy by modulating immune responses, remodeling the tumor microenvironment (TME), and producing key metabolites. Strategies such as FMT, probiotics, and dietary interventions show promise in enhancing responses to ICIs and ACTs while reducing immune-related adverse events (irAEs). This review summarizes clinical and preclinical findings and discusses microbiota-based interventions and future directions for precision immunotherapy.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba